Shayna Sarosiek, MD

Medical Oncology

Shayna Sarosiek, MD

View full profile

Related Videos

Shayna Sarosiek, MD discusses WM-NET 1 trial Video

Shayna Sarosiek, MD discusses WM-NET 1 trial

Deep responses following treatment with Ioncastuximab tesirine (WM-NET1 trial) in patients with Relapsed/Refractory including those with high risk, TP53-altered Waldenstrom macroglobulinemia.

Shayna Sarosiek, MD, Neuropathy in MGUS or Waldenstrom Macroglobulinemia Video

Shayna Sarosiek, MD, Neuropathy in MGUS or Waldenstrom Macroglobulinemia

Shayna Sarosiek, MD, at #ASH23 discusses an ongoing clinical trial at Dana-Farber that uses rituximab and acalabrutinib to treat anti-MAG neuropathy, which occurs in some patients with IgM #MGUS or #Waldenstrom macroglobulinemia.